首页> 外文OA文献 >Transforming Growth Factor-β Differentially Inhibits MyD88-dependent, but Not TRAM- and TRIF-dependent, Lipopolysaccharide-induced TLR4 Signaling

【2h】

Transforming Growth Factor-β Differentially Inhibits MyD88-dependent, but Not TRAM- and TRIF-dependent, Lipopolysaccharide-induced TLR4 Signaling

机译：转化生长因子-β差异抑制MYD88依赖性，但不是有轨电车和TRIF依赖性的脂多糖诱导的TLR4信号传导

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Yoshikazu Naiki; Kathrin S. Michelsen; Wenxuang Zhang; Shuang Chen; Terence M. Doherty; Moshe Arditi;
展开▼
作者单位

展开▼
年度 2005
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Edaravone attenuates lipopolysaccharide-induced acute respiratory distress syndrome associated early pulmonary fibrosis via amelioration of oxidative stress and transforming growth factor-β1/Smad3 signaling [J] . Xida Wang, Rongde Lai, Xiangfen Su, Biochemical and Biophysical Research Communications . 2018,第1期

机译：欧多龙酮通过改善氧化应激和转化生长因子-β1/ smad3信号传导来衰减脂多糖诱导的急性呼吸窘迫综合征相关早期肺纤维化
2. A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor-β and vascular endothelial growth factor signalling [J] . LiuY., WangZ., WangJ., Liver international : . 2013,第4期

机译：组蛋白脱乙酰基酶抑制剂largazole通过抑制转化生长因子-β和血管内皮生长因子信号转导减少肝脏纤维化和血管生成
3. R7 Photoreceptor axon growth is temporally controlled by the transcription factor Ttk69, which inhibits growth in part by promoting transforming growth factor-β/activin signaling [J] . KnissJ.S., HolbrookS., HermanT.G. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience . 2013,第4期

机译：R7感光轴突生长在时间上受转录因子Ttk69的控制，转录因子Ttk69通过促进转化生长因子-β/激活素信号传导部分抑制生长
4. Pharmacophore modeling and virtual screening for the discovery of new transforming growth factor-β type Ⅰ receptor (ALK5) inhibitors [C] . Ji-Xia Ren, Lin-Li Li, Jun Zou, ICMSI;International conference of molecular simulations and applied informatics technologies . 2010

机译：发现新的转化生长因子-βⅠ型受体（ALK5）抑制剂的药理学模型和虚拟筛选
5. Novel Signaling Mechanisms for Transforming Growth Factor-β Activated Kinase-1 (TAK1) in Microtubule and Endoplasmic Reticulum Dynamics [D] . Shah, Nirav Raju. 2018

机译：用于在微管和内质网动态中转化生长因子-β活化激酶-1（TAK1）的新型信号传导机制
6. Syndecan-2 Exerts Antifibrotic Effects by Promoting Caveolin-1–mediated Transforming Growth Factor-β Receptor I Internalization and Inhibiting Transforming Growth Factor-β1 Signaling [O] . Yuanyuan Shi, Bernadette R. Gochuico, Guoying Yu, -1

机译：Syndecan-2通过促进Caveolin-1介导的转化生长因子β受体I内化并抑制转化生长因子β1信号传导发挥抗纤维化作用。
7. Identification of BMP and Activin Membrane-bound Inhibitor (BAMBI), an Inhibitor of Transforming Growth Factor-β Signaling, as a Target of the β-Catenin Pathway in Colorectal Tumor Cells [O] . Takashi Sekiya, Shungo Adachi, Kazuyoshi Kohu, 2004

机译：鉴定BMP和Activin膜结合抑制剂（Bambi），转化生长因子-β信号传导的抑制剂，作为结直肠肿瘤细胞中β-连环蛋白途径的靶标

Transforming Growth Factor-β Differentially Inhibits MyD88-dependent, but Not TRAM- and TRIF-dependent, Lipopolysaccharide-induced TLR4 Signaling

著录项

相似文献

相关主题

期刊订阅